‌

US Patent 9169298 Dengue serotype 1 attenuated strain

Patent 9169298 was granted and assigned to Centers for Disease Control and Prevention on October, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Centers for Disease Control and Prevention

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

91692980

Date of Patent

October 27, 2015

Patent Application Number

132812400

Date Filed

October 25, 2011

Patent Primary Examiner

‌

Stacy B. Chen

Patent abstract

The invention relates to live attenuated VDV1 (VERO-Derived Dengue serotype 1 virus) strains which have been derived from the wild-type dengue-1 strain 16007 by passaging on PDK and sanitization on Vero cells and nucleic acids thereof. The invention further relates to a vaccine composition which comprises a VDV1 strain.